Health News Releases

  • Today November 13
November 12, 13:30
Abu Dhabi Future Health Summit Concludes with Research Partnerships and New Programmes to Advance Prevention and Health Innovation
Held under the patronage of His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi and Chairman of the Abu Dhabi Executive Council, Abu Dhabi Future Health Summit 2026 c
November 11, 15:50
FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor
Merck, a leading science and technology company, announced today that the U.S. Food and Drug Administration (FDA) has approved PIMJETMI® (pimicotinib), a once-daily oral colony stimulating factor-1 re
November 11, 11:40
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in MSI-High Solid Tumors
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate® MSI Dx Analysis System designed to identify patients with microsatellite high (MSI-H) solid tumors as a companion diagnos
November 11, 10:30
Nominations Open for Sixth Edition of Aster Guardians Global Nursing Award 2027 Worth USD 250,000 Prize
Aster DM Healthcare has announced the launch of the sixth edition of the Aster Guardians Global Nursing Award, inviting registered nurses worldwide to showcase their contributions to healthcare and co
November 08, 14:00
Hyperice Unveils Normatec Elite Heat Legs: Integrated Heat Meets Dynamic Air Compression in a New Fully Wireless Design
Hyperice (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fhyperice.com%2F&esheet=54635621&newsitemid=20261105782891&lan=en-US&anchor=Hyperice&index=1&md5=34106d8e2449f6ac8c60e50255ca
November 08, 12:00
Angelalign Appoints Marco Gadola as Senior Advisor
Angelalign Technology Inc. (6699.HK) (“Angel”) http://www.angelaligner.com, a global clear aligner leader, today announced that Marco Gadola has joined Angel as Senior Advisor. In this role, Marco wil
November 08, 11:00
BeOne Medicines Announces Third Quarter 2026 Financial Results and Business Updates
BeOne Medicines Ltd. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fbeonemedicines.com%2F&esheet=54635699&newsitemid=20261105790053&lan=en-US&anchor=BeOne+Medicines+Ltd.&index=1&md
November 08, 09:30
Shonan Beauty Clinic Named to Newsweek’s “World’s Best Hospitals & Clinics for Medical Tourism 2027”
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, tod
November 06, 14:20
U.S. FDA Grants Priority Review to BeOne Medicines’ BRUKINSA Combination in First-Line Mantle Cell Lymphoma
BeOne Medicines Ltd. (https://beonemedicines.com/) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the U.S. Food and Drug Administration (FDA) has accepted and
November 06, 14:10
Zenitar Announces Initiation of International Randomized Study of Flonoltinib Maleate in Patients with Myelofibrosis and Related American Society of Hematology 2026 Meeting Presentations
Chengdu Zenitar Biomedical Technology Co., Ltd. (Zenitar) is developing flonoltinib maleate (FM), a first-in-class oral JAK2/FLT3/CDK6 inhibitor for myeloproliferative neoplasms (MPNs), including myel
November 06, 13:35
Trained Therapeutix Discovery Appoints Andrew Glass as Chief Executive Officer
Trained Therapeutix Discovery (“TTxD”), a pioneering immunotherapy company founded by the Jean Boulle Group and the Heritage Group, which is developing nanomedicines to regulate innate immunity, annou
November 06, 11:55
GN Corporation’s academic event NCRM NICHE commemorates 21st anniversary of NCRM.
The XXI edition of Fujio Cup Quiz (FCQ) (https://www.fujiocupquiz.org/) in NCRM NICHE (https://www.ncrmniche.org/ncrmniche2026/agenda.html) 2026, hosted by GN Corporation (https://gncorporation.com/en
November 05, 17:25
MindWalk Announces Agreement with Teva Australia to Support Defined Antibody-Discovery Workflows
MindWalk Holdings Corp. (“MindWalk”) (NASDAQ: HYFT), a Bio-Native AI company, today announced a multi-year agreement with Teva Pharmaceuticals Australia Pty Ltd (“Teva Australia”) to deploy ReefIQ™, M
November 04, 14:00
Organigram to Acquire Aurora and Establish a Global Cannabis Leader
Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) (“Organigram”) and Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”) today announced that they have entered into an arrangement agreement (the “A
November 04, 11:30
SuperElastic* Material Unveiled by Angelalign
Angelalign Technology Inc. (6699.HK) (“Angel”)http://www.angelaligner.com, a global clear aligner leader, today unveiled SuperElastic (MC-SE*), a new propietary aligner material that is a significant
November 04, 10:40
SBC Medical Forms Capital and Business Alliance with AtomicSoftware, Provider of the medicalforce Clinic Management Platform Used by 800+ Clinics in Japan
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“The Company” or “SBC Medical”), a Medical Services Organization (MSO) providing management support across a wide range of healthcare fields, tod
November 03, 16:00
HistoSonics Receives Regulatory Approval in Singapore, Advancing Expansion Across Asia-Pacific
HistoSonics today announced that the company has received market authorization from Singapore’s Health Sciences Authority (HSA) for its Edison® Histotripsy System (under the device name HistoSonics Hi
November 03, 15:25
Agenus Announces Nature Medicine Publication of Multicenter UNICORN Phase 2 Trial Demonstrating Deep Responses with Neoadjuvant BOT+BAL in Resectable Colon Cancer
Agenus (https://www.agenusbio.com/) Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced the peer-reviewed publication of results from the investigator-sponsored, multicenter P
November 03, 10:15
Galderma Announces Proposed Board Appointments and Chief Financial Officer Transition
Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced proposed changes to its Board of Directors, aimed at further strengthening its governance and supporting its lo
November 02, 10:10
Parse Biosciences and Nomic Announce 100 Million Cell, Multimodal AI-ready Dataset for Immune Biology
Parse Biosciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.parsebiosciences.com&esheet=54630656&newsitemid=20261029559438&lan=en-US&anchor=Parse+Biosciences&index=1&md5=9e
November 02, 09:40
LeBron James Deepens Commitment to WHOOP, Expanding 11-Year Relationship
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com&esheet=54630732&newsitemid=20261029868502&lan=en-US&anchor=WHOOP&index=1&md5=8513403097c7e0799f673810576953ca), t
THE Korean Society of Ginseng holds the 14th International Symposium on Ginseng
October 30, 14:38
14th Ginseng Symposium Highlights Red Ginseng’s Multi-Targeted Benefits for Aging and Metabolic Health
Clinical and preclinical studies presented at the 14th International Symposium on Ginseng (https://www.ginsengsymposium.org/main.html), hosted by THE Korean Society of Ginseng (https://www.ginsengsoci
October 30, 10:40
Takeda Announces FY2026 First-Half Results Highlighting Launch Momentum and Pipeline Milestones
Takeda (TOKYO:4502/NYSE:TAK (https://www.takeda.com/investors/stock-information/)) announced financial results for the first half of fiscal year 2026 (April 1, 2026, to Sept. 30, 2026). The period inc
October 29, 11:40
IFF Identifies Ten Consumer Moments Reshaping Food and Beverage Innovation in the GLP-1 Era
IFF (https://www.iff.com/) (NYSE: IFF)—a global leader in flavors, fragrances and health and biosciences, today launched its latest report, “GLP-1 Consumer Moments of Opportunity.” The report uncovers
October 27, 10:50
WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN
WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2Fie%2Fen%2F&esheet=54628071&newsitemid=20261026029587&lan=en-US&anchor=WHOOP&index=1&md5=bd05ef992e790810d4dc308
25 per page50 per page75 per page100 per page